Abstract. The aim of the present study was to investigate the clinical, pathological and prognostic characteristics of Chinese patients with resected pancreatic neuroendocrine neoplasms (p-NENs). Data from patients who were surgically treated and pathologically diagnosed with p-NENs at the
Introduction
Pancreatic neuroendocrine neoplasms (p-NENs) originate from pancreatic neuroendocrine cells, and have increased in incidence in American and Asian patients during the past 20 years (1,2). To improve prognosis, Capella et al (3) developed a clinicopathological classification in 1995 according to clinical, radiographical and histopathological features. Based on this stratification, the World Health Organization (WHO; Geneva, Switzerland) published a classification system in 2000 that distinguishes well-differentiated endocrine tumors from well-differentiated and poorly differentiated endocrine carcinomas (4) . Subsequently, in 2010, the WHO updated this classification system to reflect the proliferation marker protein Ki-67 index and mitotic count (5) . In this revised classification system, p-NENs are classified as neuroendocrine tumor (NET) grade (G)1 (Ki-67 ≤2%), NET G2 (Ki-67 >2-20%), neuroendocrine carcinoma (NEC) G3 (Ki-67 >20%) and mixed adenoneuroendocrine carcinoma (5) .
In 2006 the European Neuroendocrine Tumor Society (ENETS; Berlin, Germany), and in 2010 the American Joint Cancer Committee (Chicago, IL, USA), advocated tumor-node-metastasis (TNM) staging systems for the prognosis of p-NENs (6,7), which referenced previous results from retrospective studies highlighting potential prognostic factors (5, 8) . Conversely, according to hormone secretion status and clinical presentation, p-NENs are divided into functioning and non-functioning tumors (9) . Non-functioning p-NENs may also secrete elevated amounts of hormones while remaining asymptomatic (10) . Therefore, non-functioning p-NENs frequently present later in the course of the disease with symptoms resulting from local expansion or distant metastasis (11) .
Surgical resection is the only potentially curative therapy for p-NENs, and palliative surgery is also an accepted course of action in cases of liver metastatic disease (12) (13) (14) (15) Statistical analysis. Survival estimates were constructed using the Kaplan-Meier estimator method and survival curves were compared using the log-rank test. Differences between NET G1/G2 and NEC G3 were compared by the χ 2 test. Univariate and multivariate Cox proportional hazards models were used to investigate the effects of several prognostic factors. Statistically significant factors following the univariate analysis were included in the multivariate analysis. Statistical analyses were performed using SPSS software (version 22.0; IBM SPSS, Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Patient characteristics.
The patient clinicopathological data following diagnosis are summarized in Table I . The mean age (± standard deviation) of the patients was 51.2±12.6 years and 42.6% of the patients were male. A total of 141 patients (87.0%) presented with a non-functioning tumor, whereas 21 patients (13.0%) presented with a functioning tumor. The mean tumor diameter was 4.1±2.8 cm. In 64 (39.5%) patients, the primary disease site was the pancreatic head. A total of 40 (24.7%) patients were pathologically confirmed to exhibit lymph node invasion, whereas 13 (8.0%) patients exhibited distant metastases.
All patients with locoregional or metastatic disease received surgical treatment. Pancreatoduodenectomy, distal pancreatectomy and local resection of the pancreatic tumor were the most frequently performed surgical procedures. R0 (Table III) . By contrast, gender, age, surgical approach, primary tumor size, hormone status, vessel invasion and perineural invasion had no significant effect on OS.
According to the WHO 2010 grading system, the differences in the survival time of patients classified as G1 and G3 (HR=28.134; 95% CI, 6.219-127.272; P<0.001) were statistically significant. However, a statistically significant difference between G1 and G2 was not observed (HR=2.605; 95% CI, 0.688-9.866; P=0.159). Furthermore, Ki-67 staining analysis defined a proliferative index of ≤5% as G1, between 5 and 20% as G2, and >20% as G3, providing a more efficient stratification of Chinese patients with p-NENs (G1 vs. G2, HR=4.470; 95% CI, 1.273-15.699; P=0.019; G1 vs. G3, HR=27.857; 95% CI, 7.058-109.944; P<0.001), as compared with the ENETS/WHO classification systems (Fig. 2) .
In Table IV , when the Cox proportional hazards model was adjusted for grade, residual tumor classification, lymphatic metastasis and distant metastases, NEC G3 was a significant factor for poor prognosis on multivariate analysis (HR=12.593; 95% CI, 3.476-45.622; P<0.001, vs. NET G1/G2).
Discussion
Based on the results of the present study, four prognostic factors, including lymphatic metastasis, distant metastasis, R1/R2 resection and p-NEC, predicted a poor prognosis following univariate analysis, and were subsequently used in multivariate analysis. p-NEC was an independent predictor of poor prognosis in patients with p-NEN following multivariate analysis. In addition, p-NEC exhibited increased development of lymph node metastasis compared with G1/G2 p-NET.
Conversely, the present single-center study was not able to distinguish a difference in OS between G1 and G2 tumors, using 2% as the threshold value of the Ki-67 index. The following grading index thresholds classified Chinese patients with p-NENs into three distinct survival groups more efficiently than the WHO 2010 grading classification: G1 ≤5%; G2 >5-20%; and G3 >20%.
The WHO 2010 grade classification system (5) was determined to be an independent predictor of clinical outcomes, thereby corroborating previously published studies (18, 19) . However, Bettini et al (20) published conflicting results, in which the Ki-67 index was not demonstrated to have predictive value between G1 and G2 tumors. Furthermore, certain studies have demonstrated that a Ki-67 index >5% is the most efficient predictor of recurrence following resection for p-NENs (21, 22) . In a multicenter study of 202 p-NEN cases, it was revealed that patients with a Ki-67 index of >5% had a notably unfavorable prognosis compared with patients with a Ki-67 index of >2% (8) . Rindi et al (23) also demonstrated that a Ki-67 index of 5% is more efficient, compared with 2%, for distinguishing between G1 and G2. In the receiver operating characteristic analysis of that study, the optimal threshold value for the prediction of tumor-associated mortality at five years was identified to be a Ki-67 index of ≥4.85 (23) . These findings suggest that a Ki-67 index of 5% is a more efficient threshold value to distinguish between G1 and G2 in patients with p-NENs. Therefore, the revision of the Ki-67 index threshold value for classifying G1/G2 tumors from 2 to 5% is advised.
p-NEC exhibits a poor prognosis (24) and previous evidence has demonstrated the decreased survival rate of patients with p-NEC (25, 26) . Furthermore, increased lymph node metastasis in p-NEC was observed in the present study. This difference suggested increased malignant biological behavior in p-NEC, which was consistent with other studies (19, 27) . Therefore, radical surgery with lymphadenectomy is typically recommended for the treatment of localized p-NEC (28).
There were several limitations to the present study. The mean duration of follow-up was 30.3 months, which was Table III . Univariate analysis of the clinical factors influencing the prognosis of patients with pancreatic neuroendocrine neoplasms. shorter compared with other p-NEN studies. The use of an increased sample size is necessary to confirm potential prognostic factors associated with an obvious decrease in survival. Furthermore, relapse-free survival was not analyzed due to the limitation of data integrity, and more effective models are essential in order to reduce loss to follow-up.
Univariate analysis
In conclusion, the WHO grade classification is a key prognostic factor, while p-NEC is a crucial predictor of poorer OS in Chinese patients with p-NENs. A Ki-67 staining index of 5% is a more efficient threshold value for the identification of G1 and G2. Therefore, the results of the present study suggest that the threshold for classifying G1/G2 tumors be revised from 2 to 5% in patients with p-NENs. 
Multivariate analysis Variable -----------------------------------------------------------------------------prognostic factor
Hazard ratio 95% CI P-value 
